EyePoint Pharmaceuticals
EYPT
EYPT
42 hedge funds and large institutions have $10.1M invested in EyePoint Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $13.5M → $10.1M (-$3.49M)
99% less call options, than puts
Call options by funds: $2K | Put options by funds: $169K
Holders
42
Holding in Top 10
–
Calls
$2K
Puts
$169K
Top Buyers
| 1 | +$692K | |
| 2 | +$380K | |
| 3 | +$118K | |
| 4 |
Squarepoint
New York
|
+$100K |
| 5 |
Barclays
London,
United Kingdom
|
+$57K |
Top Sellers
| 1 | -$2.57M | |
| 2 | -$1.93M | |
| 3 | -$353K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$116K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$80.2K |